| Title |
DEGRO guidelines for the radiotherapy of non-malignant disorders
|
|---|---|
| Published in |
Strahlentherapie und Onkologie, September 2014
|
| DOI | 10.1007/s00066-014-0757-3 |
| Pubmed ID | |
| Authors |
Oliver J. Ott, Marcus Niewald, Hajo-Dirk Weitmann, Ingrid Jacob, Irenaeus A. Adamietz, Ulrich Schaefer, Ludwig Keilholz, Reinhard Heyd, Ralph Muecke, German Cooperative Group on Radiotherapy for Benign Diseases (GCG-BD) |
| Abstract |
The purpose of this article is to summarize the updated DEGRO consensus S2e guideline recommendations for the treatment of benign painful degenerative skeletal disorders with low-dose radiotherapy. |
X Demographics
The data shown below were collected from the profiles of 23 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 13% |
| Spain | 2 | 9% |
| Japan | 1 | 4% |
| Chile | 1 | 4% |
| Colombia | 1 | 4% |
| Russia | 1 | 4% |
| Dominican Republic | 1 | 4% |
| Unknown | 13 | 57% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 13 | 57% |
| Scientists | 6 | 26% |
| Practitioners (doctors, other healthcare professionals) | 3 | 13% |
| Science communicators (journalists, bloggers, editors) | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 71 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Serbia | 1 | 1% |
| Germany | 1 | 1% |
| Belgium | 1 | 1% |
| Unknown | 68 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 8 | 11% |
| Student > Postgraduate | 8 | 11% |
| Student > Bachelor | 7 | 10% |
| Professor > Associate Professor | 6 | 8% |
| Student > Master | 6 | 8% |
| Other | 16 | 23% |
| Unknown | 20 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 35 | 49% |
| Nursing and Health Professions | 4 | 6% |
| Biochemistry, Genetics and Molecular Biology | 3 | 4% |
| Economics, Econometrics and Finance | 2 | 3% |
| Business, Management and Accounting | 1 | 1% |
| Other | 1 | 1% |
| Unknown | 25 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 December 2023.
All research outputs
#2,099,501
of 25,593,129 outputs
Outputs from Strahlentherapie und Onkologie
#11
of 799 outputs
Outputs of similar age
#22,153
of 261,980 outputs
Outputs of similar age from Strahlentherapie und Onkologie
#1
of 12 outputs
Altmetric has tracked 25,593,129 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 799 research outputs from this source. They receive a mean Attention Score of 3.2. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 261,980 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.